Mark Blumling is a highly qualified expert, working in Ypo main office of which is in 6. as a Member from 2019. This person gained professional experience in more than 13 positions at various companies. Mark Blumling went to the Stanford Law School and was studying there from 2002 to 2002. Berkeley, California is the city, where the professional was known to settle. Mark Blumling's phone and email can be accessed through SoftwareOfficial by request.
Name variants:
Marc Blumling,
Marcus Blumling,
Markus Blumling,
Marquis Blumling,
Mark Blumling
Last updated May 27, 2024
Contact Information
Last Update
Jul 4, 2022
Email
ma**@gmail.com
Location
Berkeley, CA
Company
Ypo
Workplace
Member
Work History
Member
600 east Las Colinas Blvd SUITE 1000, Irving, TX 75039
YPO is the premier global leadership organization of chief executives.
from 2019
Chief Executive Officer and Co-Founder at Genos
Genos is a big data healthcare marketplace company focused on consumer and enterprise customers that was spun out of Complete Genomics as a VC-backed company in early 2016, and subsequently...
2014 — 2017
President, Consumer Division and Chief Executive Officer at Genos
2904 Orchard Pkwy, San Jose, CA 95134
Led global consumer efforts at Complete Genomics, including co-founding and leading its consumer focused health care big data spin out, Genos.
Oct 2014 — May 2016
Term Member
58 east 68Th St, New York, NY 10023
The Council on Foreign Relations (CFR) is a leading independent, nonpartisan, foreign policy organization.
Jun 2010 — Jun 2015
Board of Directors Member
75 Shoreway Rd SUITE D, San Carlos, CA 94070
Executive Board member at Founders Fund backed pain drug development company focused on abuse resistant opioids.
2012 — 2014
Founder
Worked with Aetna, Founders Fund and TPG Growth on separate ventures to create, grow and invest in healthcare and technology companies.
2012 — 2013
Chief Executive Officer and Managing Director and Board Member
Led global operations for Relevare Pharmaceuticals, a Queensland Investment Corporation (QIC) backed company focused on the treatment of pain, with operations in the United States and Austra...
2008 — Dec 2011
Founder, Chief Operating Officer, and Board Member
601 Gateway Blvd SUITE 200, South San Francisco, CA 94080
Founder, COO and Board Member of Hyperion Therapeutics (NASDAQ: HPTX), a VC-backed pharmaceutical company with a commercial sales force and extensive development operations, including a rece...
2006 — 2008
Director
San Francisco, CA
Initiated, led and worked on a variety of transactions in the healthcare space, including venture capital and private equity investments, leveraged buyouts, and mergers and acquisitions.
2004 — 2006
Director of Strategy, Operations, and Business Development
Germantown, MD
Active management team member engaged by the Board to effect the turn-around of Orchid Biosciences (NASDAQ: ORCH), a company focused in healthcare services, instrumentation, and diagnostics....
2002 — 2003
Summer Associate
Worked on software and technology engagements Co-Author, "A Hard Turnaround for Software", McKinsey Quarterly, 2002.
Jun 2001 — Aug 2001
Executive Associate
Worked in the Office of Science & Technology to create, develop, and lead new alternative ventures at SmithKline Beecham in the healthcare IT space. Co-founder and CEO of healthcare IT (data...
1999 — 2000
Education
2002 — 2002
1998 — 1998
1996 — 1996
Occupations
Executive
Chief Executive Officer
Chairperson
Founder
Government Official
Premier
Health Specialist
Hospital Care Professional
Co-Founder
Corporate Executive
Chief Executive
Founding Member
Government Service Executive
Health Professional
Health Practitioner
Skills
Venture Capital
Strategy
Start Ups
Business Development
Management
Corporate Development
Private Equity
Entrepreneurship
Mergers and Acquisitions
Healthcare
Biotechnology
Lifesciences
Pharmaceutical Industry
Life Sciences
Due Diligence
Leadership
Mergers